NEW YORK (GenomeWeb) – Microbial genetics analysis firm OpGen filed a prospectus on Tuesday for an initial public offering to raise up to about $37 million. 

The Gaithersburg, Md.-based company has not priced its shares yet or said how many shares it plans to offer. It intends to list on the Nasdaq Capital Market under ticker symbol "OPGN." The Maxim Group is listed on OpGen's Form S-1 filed with the US Securities and Exchange Commission as the underwriter for the offering. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.